MORGAN STANLEY - Feb 28, 2025 Form SCHEDULE 13G/A Schedule Report for Sage Therapeutics, Inc. (SAGE)

Filing Manager
MORGAN STANLEY
Reporting Manager
Morgan Stanley
Security
Sage Therapeutics, Inc. Common Stock
Symbol
SAGE
Shares outstanding
63.3M shares
Disclosed Ownership
1.01M shares
Ownership
1.6%
Form type
SCHEDULE 13G/A
Date filed
3/6/2025, 04:28 PM
Date of event
Feb 28, 2025
Previous filing
Feb 5, 2025
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Morgan Stanley 1.6% 1.01M 0 922K Christopher O'Hara Authorized Signatory, Morgan Stanley
Morgan Stanley & Co. LLC 0.3% 173K 0 173K Christopher O'Hara Authorized Signatory, Morgan Stanley & Co. LLC